Bruce S. Spinowitz, MD; Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF
This activity is jointly provided by Global Education Group and Integritas Communications.
This activity is supported by an independent educational grant from Astrazeneca.
Bruce S. Spinowitz, MD
Clinical Professor of Medicine
Weill Medical College of Cornell University
New York, New York
Associate Director, Renal Division
Associate Chairman, Medicine
New York-Presbyterian Queens
Flushing, New York
Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF
Department of Pharmaceutical Care & Health Systems
University of Minnesota College of Pharmacy
Faculty will discuss clinically relevant pathophysiologic processes in CKD-anemia development, burdens faced by patients and health care systems, current and emerging therapeutic options, and potential changes to managed care paradigms as new medications are approved.
This activity is intended for community pharmacists and managed care professionals involved in the care of patients with anemia associated with chronic kidney disease (CKD-anemia).
Upon completion of this activity, participants should be better able to:
- Discuss the prevalence and burdens of anemia associated with CKD, including the costs of underdiagnosis, undertreatment, and safety issues with current therapies
- Explain the pathophysiologic processes underlying anemia associated with CKD, including potential therapeutic targets
- Describe the mechanisms of action, clinical trial data, and potential cost offsets associated with emerging treatment options for CKD-anemia
- Incorporate newly published data and treatment modalities into benefit design strategies to optimize health care access and outcomes for patients with CKD-anemia
Physician Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas Communications. Global is accredited by the ACCME to provide continuing medical education for physicians.
Physician Credit Designation Statement
Global designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Continuing Education
This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global and Integritas Communications. Global is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 110121. This activity is approved for 1.0 contact hour(s) (which includes 0.1 hour(s) of pharmacology).
Pharmacists Accreditation Statement
Global is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Global designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - 0530-9999-20-091-H01-P).
This is a knowledge-based activity.
Instructions to Receive Credit
In order to receive credit, participants must complete the following:
- Read the educational objectives, accreditation information, and faculty disclosures at the beginning of this activity
- Complete the Preactivity Questions.
- Read or review the activity content.
- Complete the Postactivity Test Questions and Evaluation
- Achieve a grade of 70% on the Postactivity Test Questions and complete the Evaluation to receive credit.
- Pharmacist learners must check the CPE Monitor for their credit within 60 days of the activity.
Disclosure of Conflicts of Interest
Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
The faculty reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this activity:
Bruce S. Spinowitz, MD: Consultant/Independent Contractor: Akebia, AstraZeneca, Reata Grant/Research Support: Akebia, Gilead, Reata Speaker’s Bureau: AstraZeneca, Fresenius
Wendy L. St. Peter, PharmD, FCCP, FASN, FNKF: Consultant/Independent Contractor: Optum; Total Renal Care, Inc. Grant/Research Support: Co-investigator, United States Renal Data System (current); Kidney Health Initiative (Public-Private Partnership between American Society of Nephrology and Food and Drug Administration) (current); Optum labs (current)
The planners and managers reported the following financial relationships or relationships to products or devices they or their spouses/life partners have with commercial interests related to the content of this CME activity:
Lindsay Borvansky: Nothing to disclose
Kristin Delisi, NP: Nothing to disclose
Andrea Funk: Nothing to disclose
Ashley Cann: Nothing to disclose
Liddy Knight: Nothing to disclose
Julia Muino: Nothing to disclose
Rose O’Connor, PhD, CHCP: Nothing to disclose
Jim Kappler, PhD: Nothing to disclose
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration. Global and Integritas Communications do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Fee Information & Refund/Cancellation Policy
There is no registration fee for this educational activity.
Global Contact Information
For information about the accreditation of this program, please contact Global at 303-395-1782 or firstname.lastname@example.org.
Computer System Requirements
Microsoft Windows 2000 SE or above.
Internet Explorer (v5.5 or greater), or Firefox
Internet Explorer is not supported on the Macintosh.